INFO & CONTACTS:  +39 02 2390 1
Bianca Scoppio

Dott.ssa Scoppio Bianca

Doctor

Contacts
  • Mail: biancamaria.scoppio@istitutotumori.mi.it
  • Tel: 02.23902647
Specialty / Department
  • Dermatology and Venereology

Medical doctor specialized in Dermatology and Venereology, with a degree and specialization awarded cum laude from the University of Bari. 

He has gained clinical and research experience in the field of skin oncology, with a particular focus on melanoma and Kaposi's sarcoma. He initially collaborated with the IRCCS Ca’ Granda Foundation, Policlinico of Milan, working on research projects dedicated to Kaposi’s sarcoma. 

Since 2013, he has been working with the IRCCS National Cancer Institute of Milan, where he is involved in clinical trials on innovative therapies for melanoma. His clinical expertise includes early diagnosis through epiluminescence dermoscopy and outpatient surgical procedures for cutaneous micro-tumors. 

He regularly takes part in multidisciplinary meetings dedicated to the management of melanoma and skin cancers, and practices both in the public and private healthcare sectors, with a focus on prevention, early diagnosis, and treatment of skin oncological diseases. 

“ Phase II clinical trial for the treatment of classic Kaposi's sarcoma with the HIV protease inhibitor Indinavir” 

“Phase II clinical trial for the treatment of classic Kaposi's sarcoma with the HIV protease inhibitor Indinavir in combination with chemotherapy” 

“Documented clinical and instrumental diagnosis and treatment of cutaneous micro-tumors" 

 “PH-L19IL2TNF-02/15. A pivotal Phase III, open-label, randomized, controlled multi-center study of the efficacy of L19IL2/L19TNF neoadjuvant intratumoral treatment followed by surgery versus surgery alone in clinical stage III B/C melanoma patients” 

 “COMBI-AD – BRF115532: Phase III randomized, double-blind study comparing the combination of dabrafenib (GSK2118436) and trametinib (GSK1120212) versus two placebos as adjuvant therapy for high-risk melanoma with V600 mutation after surgical resection” 

 “IMMUNE-ECT: Immune system activation following electrochemotherapy treatment – a prospective evaluation” 

Oncologic General Surgery 4 - Melanoma and Eye Tumors

Last update: 06/11/2025

Subscribe to the newsletter

Sign up for our newsletter to stay informed about news, events, and updates from the Institute

Subscribe